Valuation: DiaSorin S.p.A.

Market Cap 4.05B 4.51B 3.74B 3.39B 6.33B 430B 6.41B 44.74B 17.82B 225B 16.93B 16.57B 714B P/E 2026 *
24.8x
P/E 2027 * 21.1x
Enterprise Value 4.74B 5.28B 4.38B 3.97B 7.42B 503B 7.51B 52.41B 20.88B 263B 19.83B 19.41B 836B EV / Sales 2026 *
3.83x
EV / Sales 2027 * 3.5x
Free-Float
37.17%
Yield 2026 *
1.58%
Yield 2027 * 1.65%
1 day+1.31%
1 week+4.61%
Current month+6.46%
1 month+3.13%
3 months+15.77%
6 months+41.11%
Current year+19.15%
1 week 78.72
Extreme 78.72
81.98
1 month 72.8
Extreme 72.8
82.3
Current year 52.34
Extreme 52.34
82.3
1 year 52.34
Extreme 52.34
82.3
3 years 52.34
Extreme 52.34
112.35
5 years 52.34
Extreme 52.34
204.4
10 years 49.98
Extreme 49.98
211.8
Manager TitleAgeSince
Chief Executive Officer 60 25/03/2007
Director of Finance/CFO - 31/12/2024
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Director/Board Member 60 27/04/2016
Director/Board Member 63 25/03/2007
Chairman 57 28/04/2022
Date Insider Type Main position Quantity % Market Cap. Importance
24/03/26 Buy

Chief Executive Officer

9,211 0.0165%
28/01/26 Buy

Chief Executive Officer

7,500 0.0134%
08/01/26 Buy

Director

700 0.0013%
Change 5-day change 1-year change 3-year change Capi.($)
+1.31%+4.61%+5.85%-0.78% 4.45B
-0.45%+2.12%-18.93%+10.54% 178B
+0.86%+2.15%-19.13%+16.07% 116B
+0.88%+1.88%+1.66%+36.51% 115B
-2.26%+2.24%-44.03%+5.76% 93.1B
-0.31%-4.72%-3.36%+72.86% 62.09B
+0.17%+1.64%+8.50%+82.24% 55.87B
+0.07%+0.42%+5.94%-22.43% 53.12B
+0.30%+1.70%-11.26%+43.83% 44.22B
+0.10%+3.08%-3.06%-8.71% 33.59B
Average +0.07%+1.95%-7.78%+23.59% 75.55B
Weighted average by Cap. -0.10%+2.21%-12.56%+23.88%

Financials

2026 *2027 *
Net sales 1.24B 1.38B 1.14B 1.04B 1.93B 131B 1.96B 13.67B 5.44B 68.69B 5.17B 5.06B 218B 1.32B 1.47B 1.22B 1.1B 2.06B 140B 2.08B 14.55B 5.8B 73.13B 5.51B 5.39B 232B
Net income 181M 202M 167M 152M 283M 19.23B 287M 2B 797M 10.06B 758M 742M 31.94B 205M 228M 189M 171M 320M 21.71B 324M 2.26B 901M 11.36B 856M 837M 36.07B
Net Debt 694M 774M 642M 581M 1.09B 73.7B 1.1B 7.68B 3.06B 38.57B 2.9B 2.84B 122B 556M 619M 514M 465M 869M 58.97B 880M 6.14B 2.45B 30.86B 2.32B 2.27B 97.96B
Projected Income Statement - Annual - DiaSorin S.p.A.
Logo DiaSorin S.p.A.
DiaSorin SpA is an Italy-based company engaged in healthcare industry. The Company specializes in provision of developing, producing and commercializing reagent kits for the in vitro diagnostics. The Company develops and manufactures reagents for in vitro diagnostics and produces products for the fields of infectious disease, hepatitis, endocrinology, bone & mineral metabolism, cancer, brain injury, cardiac, therapeutic drug monitoring and autoimmunity. The Company’s business activities are divided into two markets. The Immunodiagnostics market develops, produces and markets immunoreagent kits, which are based on three techniques: Chemiluminescence (CLIA), Colorimetry (ELISA) and Radioimmunometry (RIA). The Molecular Diagnostics market supplies end laboratories with an automated result to perform the three steps for the final diagnostic result, including nucleic acids extraction, amplification and diagnosis. It operates through ELISA immunodiagnostic business portfolio.
Employees
3,260
Date Price Change Volume
28/10/26 €81.76 +1.31% 119,964
27/10/26 €80.70 -0.25% 112,380
26/10/26 €80.90 +1.48% 95,328
23/10/26 €79.72 +0.10% 165,324
22/10/26 €79.64 +1.89% 151,184
Trader
Investor
Global
Quality
ESG MSCI
BBB
MarketScreener Ratings - DiaSorin S.p.A.
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
14
Last Close Price
81.76EUR
Average target price
76.38EUR
Spread / Average Target
-6.58%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - DiaSorin S.p.A.